The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Rosenberger, Karen ^a   Derkow, Katja ^a   Dembny, Paul ^a   Krüger, Christina ^a   Schott, Eckart ^a   Lehnardt, Seija ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokines; Cytokines; Microglia; Neurodegeneration; Neuroinflammation; Pairwise TLR activation; Toll like receptors

Indexed keywords

CHAPERONIN 60; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOXORIBINE; NITRIC OXIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; AMINOQUINOLINE DERIVATIVE; CYTOKINE; ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMIQUIMOD; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; OLIGODEOXYRIBONUCLEOTIDE; PAM(3)CSK(4) PEPTIDE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INNATE IMMUNITY; MICROGLIA; MOUSE; NERVE CELL CULTURE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CEREBROSPINAL FLUID; CHEMICALLY INDUCED; DEFICIENCY; DEGENERATIVE DISEASE; DRUG EFFECTS; ENCEPHALITIS; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; METABOLISM; NERVE CELL;

AMINOQUINOLINES; ANIMALS; CELLS, CULTURED; CHAPERONIN 60; CYTOKINES; ENCEPHALITIS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NEURODEGENERATIVE DISEASES; NEURONS; NITRIC OXIDE; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOPYRUVATE HYDRATASE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84907756116     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0166-7     Document Type: Article

References (59)

1. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384. 10.1038/ni.1863, 20404851.
2. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013, 13:551-565. 10.1038/nri3479, 23846113.
3. Lee H, Lee S, Cho IH, Lee SJ. Toll-like receptors: sensor molecules for detecting damage to the nervous system. Curr Protein Pept Sci 2013, 14:33-42. 10.2174/1389203711314010006, 23441900.
4. Owens T. Toll-like receptors in neurodegeneration. Curr Top Microbiol Immunol 2009, 336:105-120. 19688330.
5. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002, 61:1013-1021. 12430718.
6. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320-4330. 10.4049/jimmunol.175.7.4320, 16177072.
7. Lehmann SM, Rosenberger K, Kruger C, Habbel P, Derkow K, Kaul D, Rybak A, Brandt C, Schott E, Wulczyn FG, Lehnardt S. Extracellularly delivered single-stranded viral RNA causes neurodegeneration dependent on TLR7. J Immunol 2012, 189:1448-1458. 10.4049/jimmunol.1201078, 22745379.
8. Kaul D, Habbel P, Derkow K, Kruger C, Franzoni E, Wulczyn FG, Bereswill S, Nitsch R, Schott E, Veh R, Naumann T, Lehnardt S. Expression of Toll-like receptors in the developing brain. PLoS One 2012, 7:e37767. 10.1371/journal.pone.0037767, 22666391.
9. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007, 104:13798-13803. 10.1073/pnas.0702553104, 17693552.
10. Kim Y, Zhou P, Qian L, Chuang JZ, Lee J, Li C, Iadecola C, Nathan C, Ding A. MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J Exp Med 2007, 204:2063-2074. 10.1084/jem.20070868, 17724133.
11. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H, Nietfeld W, Trendelenburg G. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 2007, 359:574-579. 10.1016/j.bbrc.2007.05.157, 17548055.
12. Mishra BB, Gundra UM, Teale JM. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflammation 2008, 5:53. 10.1186/1742-2094-5-53, 19077284.
13. Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 2011, 121:367-387. 10.1042/CS20110164.
14. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019. 10.1093/brain/awl249, 16984903.
15. Weber JR, Tuomanen EI. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol 2007, 184:45-52. 10.1016/j.jneuroim.2006.11.016, 17210186.
16. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kälin R, Franzoni E, Rybak A, Nguyen D, Veh R, Ninnemann O, Peters O, Nitsch R, Heppner FL, Golenbock D, Schott E, Ploegh HL, Wulczyn FG, Lehnardt S. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 2012, 15:827-835. 10.1038/nn.3113, 22610069.
17. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250-256. 10.1016/0006-8993(92)91004-X, 1381982.
18. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 2008, 28:2320-2331. 10.1523/JNEUROSCI.4760-07.2008, 18322079.
19. Hoffmann O, Braun JS, Becker D, Halle A, Freyer D, Dagand E, Lehnardt S, Weber JR. TLR2 mediates neuroinflammation and neuronal damage. J Immunol 2007, 178:6476-6481. 10.4049/jimmunol.178.10.6476, 17475877.
20. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100:8514-8519. 10.1073/pnas.1432609100, 12824464.
21. Rieu I, Powers SJ. Real-time quantitative RT-PCR: design, calculations, and statistics. Plant Cell 2009, 21:1031-1033. 10.1105/tpc.109.066001, 19395682.
22. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173:3916-3924. 10.4049/jimmunol.173.6.3916, 15356140.
23. Ebert S, Gerber J, Bader S, Muhlhauser F, Brechtel K, Mitchell TJ, Nau R. Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J Neuroimmunol 2005, 159:87-96. 10.1016/j.jneuroim.2004.10.005, 15652406.
24. Bessler WG, Johnson RB, Wiesmuller K, Jung G. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. Hoppe Seylers Z Physiol Chem 1982, 363:767-770. 10.1515/bchm2.1982.363.2.767, 6751983.
25. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002, 169:10-14. 10.4049/jimmunol.169.1.10, 12077222.
26. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169:6668-6672. 10.4049/jimmunol.169.12.6668, 12471095.
27. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329. 10.1038/nature01182, 12447441.
28. Lehnardt S, Henneke P, Lien E, Kasper DL, Volpe JJ, Bechmann I, Nitsch R, Weber JR, Golenbock DT, Vartanian T. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol 2006, 177:583-592. 10.4049/jimmunol.177.1.583, 16785556.
29. Iliev AI, Stringaris AK, Nau R, Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). Faseb J 2004, 18:412-414. 14688201.
30. Lehnardt S, Wennekamp J, Freyer D, Liedtke C, Krueger C, Nitsch R, Bechmann I, Weber JR, Henneke P. TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. J Immunol 2007, 179:6134-6143. 10.4049/jimmunol.179.9.6134, 17947688.
31. Bottcher T, von Mering M, Ebert S, Meyding-Lamade U, Kuhnt U, Gerber J, Nau R. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett 2003, 344:17-20. 10.1016/S0304-3940(03)00404-X, 12781911.
32. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 2002, 169:3970-3977. 10.4049/jimmunol.169.7.3970, 12244198.
33. Nicolle D, Fremond C, Pichon X, Bouchot A, Maillet I, Ryffel B, Quesniaux VJ. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect Immun 2004, 72:6994-7004. 10.1128/IAI.72.12.6994-7004.2004, 15557622.
34. Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581. 10.1038/nri1130, 12876559.
35. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289. 10.1038/nri2215, 18340345.
36. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 2007, 190:28-33. 10.1016/j.jneuroim.2007.07.023, 17854911.
37. Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister HW, Kirschning CJ. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol 2003, 170:438-444. 10.4049/jimmunol.170.1.438, 12496429.
38. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000, 165:7096-7101. 10.4049/jimmunol.165.12.7096, 11120839.
39. Beutler E, Gelbart T, West C. Synergy between TLR2 and TLR4: a safety mechanism. Blood Cells Mol Dis 2001, 27:728-730. 10.1006/bcmd.2001.0441, 11778656.
40. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007, 178:1164-1171. 10.4049/jimmunol.178.2.1164, 17202381.
41. Gao JJ, Xue Q, Papasian CJ, Morrison DC. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J Immunol 2001, 166:6855-6860. 10.4049/jimmunol.166.11.6855, 11359845.
42. Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 1999, 163:4095-4099. 10510342.
43. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008, 19:41-52. 10.1016/j.cytogfr.2007.10.004, 18258476.
44. Wang J, Shao Y, Bennett TA, Shankar RA, Wightman PD, Reddy LG. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 2006, 281:37427-37434. 10.1074/jbc.M605311200, 17040905.
45. Berghofer B, Haley G, Frommer T, Bein G, Hackstein H. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production. J Immunol 2007, 178:4072-4079. 10.4049/jimmunol.178.7.4072, 17371961.
46. Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand. J Leukoc Biol 2007, 82:497-508. 10.1189/jlb.0906575, 17565046.
47. Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 2010, 58:650-664. 19998480.
48. Hailer NP, Jarhult JD, Nitsch R. Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 1996, 18:319-331. 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S, 8972800.
49. Tauber SC, Ebert S, Weishaupt JH, Reich A, Nau R, Gerber J. Stimulation of Toll-like receptor 9 by chronic intraventricular unmethylated cytosine-guanine DNA infusion causes neuroinflammation and impaired spatial memory. J Neuropathol Exp Neurol 2009, 68:1116-1124. 10.1097/NEN.0b013e3181b7fde5, 19918123.
50. Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S, Xiang J, Li JC, Fang CQ, Wang JZ. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 2011, 31:593-605. 10.1038/jcbfm.2010.129, 20700129.
51. Dalpke AH, Lehner MD, Hartung T, Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 2005, 116:203-212. 10.1111/j.1365-2567.2005.02211.x, 16162269.
52. Mallard C. Innate immune regulation by toll-like receptors in the brain. ISRN Neurol 2012, 2012:701950. 10.5402/2012/701950, 23097717.
53. Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab 2007, 27:1663-1674. 10.1038/sj.jcbfm.9600464, 17327883.
54. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2008, 28:1040-1047. 10.1038/sj.jcbfm.9600606, 18183029.
55. Hua F, Ma J, Ha T, Kelley J, Williams DL, Kao RL, Kalbfleisch JH, Browder IW, Li C. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 2008, 199:75-82. 10.1016/j.jneuroim.2008.05.009, 18585792.
56. Pradillo JM, Fernandez-Lopez D, Garcia-Yebenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem 2009, 109:287-294. 10.1111/j.1471-4159.2009.05972.x, 19200341.
57. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004, 10:71-84. 10.1179/096805104225003997, 15119998.
58. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318. 10.1016/0166-2236(96)10049-7, 8843599.
59. Henderson B, Calderwood SK, Coates AR, Cohen I, van Eden W, Lehner T, Pockley AG. Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants. Cell Stress Chaperones 2010, 15:123-141. 10.1007/s12192-009-0137-6, 19731087.